JVM Co

JVM Co Gross Margin

The Gross Margin of JVM Co (054950.KQ) as of Nov 4, 2026 is 40.92 %. In the previous year, Gross Margin was 39.97 % — a change of 2.37% (higher).

Gross Margin

40.92 %

YoY

2.37%

Last updated:

Gross Margin of JVM Co is 2025 40.92 % . Gross Margin of JVM Co was 2024 39.97 % . It decreases by 2.37% higher compared to the previous year.

JVM Co's gross margin stands at 40.9%, up from 33.9% several years earlier.

The JVM Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
38.78 KRW
Jan 1, 2019
35.53 KRW
Jan 1, 2020
36.38 KRW
Jan 1, 2021
33.89 KRW
Jan 1, 2022
36.03 KRW
Jan 1, 2023
39.85 KRW
Jan 1, 2024
39.97 KRW
Jan 1, 2025
40.92 KRW
The JVM Co Gross Margin history
YEARGross MarginYoY
40.92 %+2.37%
39.97 %+0.30%
39.85 %+10.59%
36.03 %+6.33%
33.89 %-6.85%
36.38 %+2.37%
35.53 %-8.36%
38.78 %-8.76%
42.50 %-2.16%
43.44 %-0.28%
43.56 %+4.08%
41.85 %+9,753.08%
0.42 %-0.21%
0.43 %-6.54%
0.46 %+6.07%
0.43 %-7.34%
0.46 %-17.56%
0.56 %+8.97%
0.52 %+1.68%
0.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Gross Margin of JVM Co is 40.92 % in 2025.

Gross Margin of JVM Co changed from 39.97 % to 40.92 %, representing a 2.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin JVM Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — JVM Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — JVM Co